In prostate cancer, prostate brachytherapy boost improves biochemical failure at 10 years but does not prolong long-term OS compared to EBRT boost.

Learn the key warning signs of prostate cancer that men often overlook. Early awareness can make all the difference.

Other than skin cancer, prostate cancer is the most common type of cancer in men in the U.S. In 2025, almost 314,000 people will be diagnosed with prostate cancer, the National Cancer Institute ...

Chimeric antigen receptor (CAR)-T cells — immune cells that have been modified to express an artificial receptor that enables them to recognize and attack tumours — are already used to treat blood ...

Even when diagnosed at an advanced stage, most prostate cancers respond well to treatment. The first line of treatment is often hormone therapy, which is very good at slowing or stopping the cancer — ...

Medicare covers screenings and treatment for prostate cancer, with Part A covering hospital care and Part B covering outpatient care and outpatient cancer medications. Original Medicare (parts A and B ...

Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...